Substitution of care within benign gynecology during the COVID-19 pandemic in the Netherlands
- Funded by Netherlands Organisation for Health Research and Development (ZonMW)
- Total publications:3 publications
Grant number: 05160482240003
Grant search
Key facts
Disease
COVID-19Start & end year
20232025Funder
Netherlands Organisation for Health Research and Development (ZonMW)Principal Investigator
dr. prof WJK HehenkampResearch Location
N/ALead Research Institution
Amsterdam UMC Locatie VUmcResearch Priority Alignment
N/A
Research Category
Secondary impacts of disease, response & control measuresResearch Subcategory
Indirect health impactsSpecial Interest Tags
N/AStudy Type
Non-ClinicalClinical Trial Details
N/ABroad Policy Alignment
PendingAge Group
UnspecifiedVulnerable Population
UnspecifiedOccupations of Interest
Unspecified
Abstract
During the COVID-19 pandemic, less surgery was performed than before (or after). Elective care surrounding benign diseases has been particularly hard hit; after all, priority was given to acute and oncological surgery. In benign gynecology, surgical elective care has virtually come to a standstill. It is obvious that alternative treatments have been offered to these patients during the COVID-19 period. Purpose and method With this research we will find out which care was provided instead of operations and how satisfied patients and caregivers were with this. With this information we can draw up a protocol for which care should be offered and how in a new period of absolute scarcity. But even in the case of relative scarcity, one can learn from substituted care: if patients are equally satisfied with non-operative treatment, operations may be performed less frequently. This can contribute to lower healthcare costs and relieve the burden on staff.
3 Publications linked via Europe PMC
Last Updated:4 days ago
View all publications at Europe PMC